Literature DB >> 23878634

Is sulphadoxine-pyrimethamine (SP) still useful as the first-line antimalarial drug in Malawi or it must be quickly withdrawn from the antimalarial repertoire?

Standwell Nkhoma1.   

Abstract

Entities:  

Year:  2007        PMID： 23878634      PMCID： PMC3615317     

Source DB:  PubMed          Journal:  Malawi Med J        ISSN： 1995-7262            Impact factor:   0.875


× No keyword cloud information.
  17 in total

1.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.

Authors:  C V Plowe; J F Cortese; A Djimde; O C Nwanyanwu; W M Watkins; P A Winstanley; J G Estrada-Franco; R E Mollinedo; J C Avila; J L Cespedes; D Carter; O K Doumbo
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

2.  Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi.

Authors:  F H Verhoeff; B J Brabin; P Masache; B Kachale; P Kazembe; H J Van der Kaay
Journal:  Ann Trop Med Parasitol       Date:  1997-03

3.  Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.

Authors:  D L Heymann; C O Khoromana; J J Wirima; C C Campbell
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

4.  Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy.

Authors:  C V Plowe; O K Doumbo; A Djimde; K Kayentao; Y Diourte; S N Doumbo; D Coulibaly; M Thera; T E Wellems; D A Diallo
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

5.  Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of P. falciparum isolates to sulphadoxine-pyremethamine and other antimalarial drugs in Malawian children.

Authors:  M Takechi; M Matsuo; C Ziba; A MacHeso; D Butao; I L Zungu; I Chakanika; M D Bustos
Journal:  Trop Med Int Health       Date:  2001-06       Impact factor: 2.622

6.  Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age.

Authors:  O C Nwanyanwu; C Ziba; P Kazembe; L Chitsulo; J J Wirima; N Kumwenda; S C Redd
Journal:  Trop Med Int Health       Date:  1996-04       Impact factor: 2.622

7.  Return of chloroquine antimalarial efficacy in Malawi.

Authors:  Miriam K Laufer; Phillip C Thesing; Nicole D Eddington; Rhoda Masonga; Fraction K Dzinjalamala; Shannon L Takala; Terrie E Taylor; Christopher V Plowe
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

Review 8.  Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy.

Authors:  Eline L Korenromp; Brian G Williams; Eleanor Gouws; Christopher Dye; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2003-06       Impact factor: 25.071

9.  Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.

Authors:  Christopher V Plowe; James G Kublin; Fraction K Dzinjalamala; Deborah S Kamwendo; Rabia A G Mukadam; Phillips Chimpeni; Malcolm E Molyneux; Terrie E Taylor
Journal:  BMJ       Date:  2004-02-02

10.  Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria.

Authors:  Abdoulaye A Djimdé; Ogobara K Doumbo; Ousmane Traore; Ando B Guindo; Kassoum Kayentao; Yacouba Diourte; Safiatou Niare-Doumbo; Drissa Coulibaly; Abdoulaye K Kone; Yacouba Cissoko; Mamadou Tekete; Bakary Fofana; Alassane Dicko; Dapa A Diallo; Thomas E Wellems; Dominic Kwiatkowski; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2003-11       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.